Aquarius Surgical Technologies Full Year 2025 Earnings: CA$0.042 loss per share (vs CA$0.027 loss in FY 2024)

Simply Wall St

Aquarius Surgical Technologies (CSE:ASTI) Full Year 2025 Results

Key Financial Results

  • Net loss: CA$1.17m (loss widened by 54% from FY 2024).
  • CA$0.042 loss per share (further deteriorated from CA$0.027 loss in FY 2024).

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

CNSX:ASTI Earnings and Revenue History July 30th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Aquarius Surgical Technologies shares are up 67% from a week ago.

Risk Analysis

You should learn about the 5 warning signs we've spotted with Aquarius Surgical Technologies.

Valuation is complex, but we're here to simplify it.

Discover if Aquarius Surgical Technologies might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.